Vigil Neuroscience Welcomes Petra Kaufmann as Chief Medical Officer

Wednesday, 20 March 2024, 11:50

Vigil Neuroscience (VIGL) has appointed Petra Kaufmann as its new Chief Medical Officer, succeeding Christopher J. Silber. Kaufmann's extensive experience as a former Chief Medical Officer brings a wealth of knowledge and expertise to Vigil Neuroscience. Her appointment signifies a strategic move towards further medical innovation and leadership within the company.

LivaRava Finance Meta Image — Vigil Neuroscience Welcomes Petra Kaufmann as Chief Medical Officer

News: Vigil Neuroscience Appoints Petra Kaufmann as Chief Medical Officer

Vigil Neuroscience (VIGL) has announced the appointment of Petra Kaufmann as the new Chief Medical Officer to succeed Christopher J. Silber.

Background

Kaufmann's recent role as a Chief Medical Officer showcases her expertise in the medical field.

The appointment of Kaufmann as the new Chief Medical Officer of Vigil Neuroscience marks a significant development for the company.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.